Cargando…

The Effect of Vitamin D Supplementation on Skeletal Muscle in the mdx Mouse Model of Duchenne Muscular Dystrophy

Vitamin D (VitD) has shown to be beneficial in reversing muscle weakness and atrophy associated with VitD deficiency. Duchenne muscular dystrophy is characterized by worsening muscle weakness and muscle atrophy, with VitD deficiency commonly observed. This study aimed to investigate the effect of Vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Debruin, Danielle A., Andreacchio, Nicola, Hanson, Erik D., Timpani, Cara A., Rybalka, Emma, Hayes, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572350/ https://www.ncbi.nlm.nih.gov/pubmed/31035483 http://dx.doi.org/10.3390/sports7050096

Ejemplares similares

The Failed Clinical Story of Myostatin Inhibitors against Duchenne Muscular Dystrophy: Exploring the Biology behind the Battle
por: Rybalka, Emma, et al.
Publicado: (2020)

Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy
por: Rybalka, Emma, et al.
Publicado: (2015)

Nitric Oxide (NO) and Duchenne Muscular Dystrophy: NO Way to Go?
por: Timpani, Cara A., et al.
Publicado: (2020)

Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy
por: Timpani, Cara A., et al.
Publicado: (2017)

Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy
por: Kourakis, Stephanie, et al.
Publicado: (2020)

Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy
por: Timpani, Cara A., et al.
Publicado: (2020)

Exercise May Ameliorate the Detrimental Side Effects of High Vitamin D Supplementation on Muscle Function in Mice
por: Debruin, Danielle A, et al.
Publicado: (2020)

Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?
por: Kourakis, Stephanie, et al.
Publicado: (2021)

Defects in Mitochondrial ATP Synthesis in Dystrophin-Deficient Mdx Skeletal Muscles May Be Caused by Complex I Insufficiency
por: Rybalka, Emma, et al.
Publicado: (2014)

Social stress is lethal in the mdx model of Duchenne muscular dystrophy
por: Razzoli, Maria, et al.
Publicado: (2020)

The Effect of Yearly-Dose Vitamin D Supplementation on Muscle Function in Mice
por: Hayes, Alan, et al.
Publicado: (2019)

Sodium nitrate co-supplementation does not exacerbate low dose metronomic doxorubicin-induced cachexia in healthy mice
por: Campelj, Dean G., et al.
Publicado: (2020)

The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy
por: Hammers, David W., et al.
Publicado: (2020)

Characterisation of Progressive Skeletal Muscle Fibrosis in the Mdx Mouse Model of Duchenne Muscular Dystrophy: An In Vivo and In Vitro Study
por: Giovarelli, Matteo, et al.
Publicado: (2022)

RANKL Inhibition Reduces Cardiac Hypertrophy in mdx Mice and Possibly in Children with Duchenne Muscular Dystrophy
por: Marcadet, Laetitia, et al.
Publicado: (2023)

Skeletal Muscle Fibrosis in the mdx/utrn+/- Mouse Validates Its Suitability as a Murine Model of Duchenne Muscular Dystrophy
por: Gutpell, Kelly M., et al.
Publicado: (2015)

Mitochondrial bioenergetic dysfunction in the D2.mdx model of Duchenne muscular dystrophy is associated with microtubule disorganization in skeletal muscle
por: Ramos, Sofhia V., et al.
Publicado: (2020)

Ventilatory Chemosensory Drive Is Blunted in the mdx Mouse Model of Duchenne Muscular Dystrophy (DMD)
por: Mosqueira, Matias, et al.
Publicado: (2013)

Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy
por: Miglietta, Daniela, et al.
Publicado: (2015)

Comparison of Experimental Protocols of Physical Exercise for mdx Mice and Duchenne Muscular Dystrophy Patients
por: Hyzewicz, Janek, et al.
Publicado: (2015)

Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy
por: van Putten, Maaike, et al.
Publicado: (2019)

In vivo cerebellar circuit function is disrupted in an mdx mouse model of Duchenne muscular dystrophy
por: Stay, Trace L., et al.
Publicado: (2019)

Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy
por: Saoudi, Amel, et al.
Publicado: (2021)

miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2022)

A Novel Method for Detecting Duchenne Muscular Dystrophy in Blood Serum of mdx Mice
por: Ralbovsky, Nicole M., et al.
Publicado: (2022)

Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle
por: Lorena, Marcelo dos Santos Voltani, et al.
Publicado: (2023)

Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle
por: Lorena, Marcelo dos Santos Voltani, et al.
Publicado: (2023)

Humanization of the mdx Mouse Phenotype for Duchenne Muscular Dystrophy Modeling: A Metabolic Perspective
por: Donen, Graham, et al.
Publicado: (2023)

Prednisolone Attenuates Improvement of Cardiac and Skeletal Contractile Function and Histopathology by Lisinopril and Spironolactone in the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Janssen, Paul M. L., et al.
Publicado: (2014)

Revertant Fibers in the mdx Murine Model of Duchenne Muscular Dystrophy: An Age- and Muscle-Related Reappraisal
por: Pigozzo, Sarah R., et al.
Publicado: (2013)

Dystropathology Increases Energy Expenditure and Protein Turnover in the Mdx Mouse Model of Duchenne Muscular Dystrophy
por: Radley-Crabb, Hannah G., et al.
Publicado: (2014)

Disease course in mdx:utrophin(+/−) mice: comparison of three mouse models of Duchenne muscular dystrophy
por: McDonald, Abby A, et al.
Publicado: (2015)

Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy
por: Aranmolate, Azeez, et al.
Publicado: (2017)

Cardiovascular phenotype of the Dmd(mdx) rat – a suitable animal model for Duchenne muscular dystrophy
por: Szabó, Petra Lujza, et al.
Publicado: (2021)

Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular Dystrophy
por: Ponzetti, Marco, et al.
Publicado: (2022)

Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy
por: Boccanegra, Brigida, et al.
Publicado: (2023)

Expression and function of four AAV-based constructs for dystrophin restoration in the mdx mouse model of Duchenne muscular dystrophy
por: Potter, Rachael A., et al.
Publicado: (2023)

Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse
por: Merckx, Caroline, et al.
Publicado: (2022)

Intraosseous transplant of dystrophin expressing chimeric (DEC) cells improves skeletal muscle function in mdx mouse model of Duchenne muscular dystrophy
por: Malik, Mohammad, et al.
Publicado: (2021)

Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome
por: Griffin, Julian L, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_dgeejrbv7pn7j4eu6vgaj6udco